0      0

2020 ISPE Biotechnology Virtual Conference


EU20CEOCT1/SES402 - Regulatory and Quality Considerations for mRNA-based Medicinal Products


Oct 8, 2020 8:55am ‐ Oct 8, 2020 9:20am

Description

Regulatory and Quality Considerations for mRNA-based Medicinal Products |

Speaker(s):

  • Andreas Kuhn, Vice President RNA Biochemistry & Manufacturing, BioNTech RNA Pharmaceuticals GmbH

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content